Integrating Autoantibody Profiles and Disease Activity for the Prediction of Neuropsychiatric Involvement in Systemic Lupus Erythematosus
Nicole Al Alam-Rabie1, María de los Ángeles Álvarez-Falcón1, Michael Feijoo-Jaramillo1, Grace Cedeño-Castro1, Xavier Grandes1
1Research, Catholic University of Santiago of Guayaquil
Objective:
To identify autoantibodies and SLEDAI scores that predict neuropsychiatric manifestations in Hispanic patients with systemic lupus erythematosus (SLE).
Background:

Neuropsychiatric systemic lupus erythematosus (NPSLE) includes a broad spectrum of central and peripheral nervous system disorders that significantly impact morbidity and quality of life. Identifying clinical and immunological factors associated with neuropsychiatric symptoms is essential to improve diagnostic accuracy and guide targeted interventions.

Design/Methods:

A cross-sectional study was conducted in patients with SLE, recording clinical and serological data. Neuropsychiatric manifestations and disease activity (SLEDAI) were evaluated. Mann-Whitney U tests and binary logistic regression (95% OR, p < 0.05) were applied.

Results:

Among 161 patients with SLE, 87% (n = 140) were female, with a mean age of 44 ± 12.35 years. Neuropsychiatric symptoms were present in 55.9% (n = 90), mainly anxiety (26.7%), insomnia (21.1%), headache (20.5%) and depression (19.9%). Higher SLEDAI scores were associated with anxiety (Exp(B)=1.10; p<0.001), depression (Exp(B)=1.08; p=0.004), seizures (Exp(B)=1.12; p=0.001), headache (Exp(B)=1.12; p<0.001), insomnia (Exp(B)=1.07; p=0.004), neuropathy (Exp(B)=1.13; p=0.003), and cognitive impairment (Exp(B)=1.21; p=0.005). ANA antibodies were protective against anxiety (Exp(B)=0.18; p=0.004) but associated with cognitive impairment (Exp(B)=25.86; p=0.040). ANCA antibodies showed a protective effect against headache (Exp(B)=0.26; p=0.029). Neuralgia, encephalitis, and myelitis showed no significant associations. Disease duration was not related to neuropsychiatric manifestations (p=0.067). Twelve patients (7.5%) died, with no significant association with NPSLE (p=0.860).

Conclusions:
Neuropsychiatric manifestations are correlated with higher SLEDAI scores, reflecting systemic inflammation. ANA and ANCA showed variable predictive roles, supporting their integration with disease activity for early prediction and personalized management of neuropsychiatric lupus.
10.1212/WNL.0000000000216678
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.